These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36031379)

  • 1. [Sibling cases of four and a half LIM domains 1 (FHL1) myopathy who developed respiratory failure without apparent limb weakness].
    Aohara K; Kimura H; Takeda A; Izumiya Y; Nishino I; Itoh Y
    Rinsho Shinkeigaku; 2022 Sep; 62(9):726-731. PubMed ID: 36031379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel FHL1 mutation variant identified in a patient with nonobstructive hypertrophic cardiomyopathy and myopathy - a case report.
    Giucă A; Mitu C; Popescu BO; Bastian AE; Capşa R; Mursă A; Rădoi V; Popescu BA; Jurcuţ R
    BMC Med Genet; 2020 Sep; 21(1):188. PubMed ID: 32993534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myofibrillar myopathy caused by a novel FHL1 mutation presenting a mild myopathy with ankle contracture.
    Park YE; Kim DS; Shin JH
    Clin Neurol Neurosurg; 2019 May; 180():48-51. PubMed ID: 30928807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FHL1-related myopathy may not be classified by reducing bodies in muscle biopsy.
    Chen T; Lu X; Shi Q; Guo J; Wang H; Wang Q; Yin X; Zhang Y; Pu C; Zhou D
    Neuromuscul Disord; 2020 Feb; 30(2):165-172. PubMed ID: 32001145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial reducing body myopathy with cytoplasmic bodies and rigid spine revisited: identification of a second LIM domain mutation in FHL1.
    Schessl J; Columbus A; Hu Y; Zou Y; Voit T; Goebel HH; Bönnemann CG
    Neuropediatrics; 2010 Feb; 41(1):43-6. PubMed ID: 20571991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective muscle involvement in a family affected by a second LIM domain mutation of fhl1: an imaging study using computed tomography.
    Komagamine T; Kawai M; Kokubun N; Miyatake S; Ogata K; Hayashi YK; Nishino I; Hirata K
    J Neurol Sci; 2012 Jul; 318(1-2):163-7. PubMed ID: 22541254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1.
    Schessl J; Taratuto AL; Sewry C; Battini R; Chin SS; Maiti B; Dubrovsky AL; Erro MG; Espada G; Robertella M; Saccoliti M; Olmos P; Bridges LR; Standring P; Hu Y; Zou Y; Swoboda KJ; Scavina M; Goebel HH; Mitchell CA; Flanigan KM; Muntoni F; Bönnemann CG
    Brain; 2009 Feb; 132(Pt 2):452-64. PubMed ID: 19181672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing body myopathy and other FHL1-related muscular disorders.
    Schessl J; Feldkirchner S; Kubny C; Schoser B
    Semin Pediatr Neurol; 2011 Dec; 18(4):257-63. PubMed ID: 22172421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel FHL1 mutation in a family with reducing body myopathy.
    Schreckenbach T; Henn W; Kress W; Roos A; Maschke M; Feiden W; Dillmann U; Schulz JB; Weis J; Claeys KG
    Muscle Nerve; 2013 Jan; 47(1):127-34. PubMed ID: 23169582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fhl1 W122S causes loss of protein function and late-onset mild myopathy.
    Emmanuele V; Kubota A; Garcia-Diaz B; Garone C; Akman HO; Sánchez-Gutiérrez D; Escudero LM; Kariya S; Homma S; Tanji K; Quinzii CM; Hirano M
    Hum Mol Genet; 2015 Feb; 24(3):714-26. PubMed ID: 25274776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1.
    Windpassinger C; Schoser B; Straub V; Hochmeister S; Noor A; Lohberger B; Farra N; Petek E; Schwarzbraun T; Ofner L; Löscher WN; Wagner K; Lochmüller H; Vincent JB; Quasthoff S
    Am J Hum Genet; 2008 Jan; 82(1):88-99. PubMed ID: 18179888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disorders.
    Malfatti E; Olivé M; Taratuto AL; Richard P; Brochier G; Bitoun M; Gueneau L; Laforêt P; Stojkovic T; Maisonobe T; Monges S; Lubieniecki F; Vasquez G; Streichenberger N; Lacène E; Saccoliti M; Prudhon B; Alexianu M; Figarella-Branger D; Schessl J; Bonnemann C; Eymard B; Fardeau M; Bonne G; Romero NB
    J Neuropathol Exp Neurol; 2013 Sep; 72(9):833-45. PubMed ID: 23965743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-linked Recessive Distal Myopathy With Hypertrophic Cardiomyopathy Caused by a Novel Mutation in the FHL1 Gene.
    D'Arcy C; Kanellakis V; Forbes R; Wilding B; McGrath M; Howell K; Ryan M; McLean C
    J Child Neurol; 2015 Aug; 30(9):1211-7. PubMed ID: 25246303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene.
    Sarkozy A; Windpassinger C; Hudson J; Dougan CF; Lecky B; Hilton-Jones D; Eagle M; Charlton R; Barresi R; Lochmüller H; Bushby K; Straub V
    Eur J Hum Genet; 2011 Oct; 19(10):1038-44. PubMed ID: 21629301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiomyopathy and altered integrin-actin signaling in Fhl1 mutant female mice.
    Kubota A; Juanola-Falgarona M; Emmanuele V; Sanchez-Quintero MJ; Kariya S; Sera F; Homma S; Tanji K; Quinzii CM; Hirano M
    Hum Mol Genet; 2019 Jan; 28(2):209-219. PubMed ID: 30260394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A zebrafish model for FHL1-opathy reveals loss-of-function effects of human FHL1 mutations.
    Keßler M; Kieltsch A; Kayvanpour E; Katus HA; Schoser B; Schessl J; Just S; Rottbauer W
    Neuromuscul Disord; 2018 Jun; 28(6):521-531. PubMed ID: 29735270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing body myopathy associated with the LIM2 p.(His123Arg) FHL1 variant.
    Darki L; Jalali-Sohi A; Guzman S; Mathew AJ; Bucelli RC; Hurth KM; Beydoun SR
    Clin Neurol Neurosurg; 2021 Aug; 207():106795. PubMed ID: 34273663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel FHL1 mutations associated with X-linked scapuloperoneal myopathy in unrelated Chinese patients.
    Lin Y; Ban R; Qiao L; Chen J; Liu M; Liu J; Shi Q
    J Hum Genet; 2023 Jul; 68(7):477-484. PubMed ID: 36864287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy.
    Selcen D; Bromberg MB; Chin SS; Engel AG
    Neurology; 2011 Nov; 77(22):1951-9. PubMed ID: 22094483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FHL1-mutated reducing body myopathy.
    Lim KY; Kim HH; Sung JJ; Oh BM; Kim K; Park SH
    Neuropathology; 2020 Apr; 40(2):185-190. PubMed ID: 31803991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.